Filing Details
- Accession Number:
- 0001144204-16-100933
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-05-11 17:21:18
- Reporting Period:
- 2016-05-11
- Filing Date:
- 2016-05-11
- Accepted Time:
- 2016-05-11 17:21:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1430306 | Tonix Pharmaceuticals Holding Corp. | TNXP | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1180469 | Ernest Mario | C/O Tonix Pharmaceuticals Holding Corp. 509 Madison Avenue, Suite 306 New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.001 Par Value | Acquisiton | 2016-05-11 | 8,210 | $2.24 | 349,682 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The common stock was purchased by the reporting person in open market transactions on the transaction date, with a volume weighted average purchase price of $2.241139. The range of purchase prices on the transaction date was $2.22 to $2.25 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each price.